Amid the COVID-19 crisis, the United States Continuous Glucose Monitoring (CGM) was valued at $2,830 Million in 2021 and is expected to grow at a CAGR of 11.5% in the forecast period, to reach $6,000 Million by 2028.
The Prominent Factors that are Expected to Contribute to the Growth of the United States Continuous Glucose Monitoring
• Rising Incidence of Diabetes
• Minimally Invasive in Nature
• Less Painful
• Real-Time Monitoring
• Rapid and Precise Results
• New Product Launches
• Supportive Government Initiatives
• Growing Awareness About Diabetes Preventive Care
After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States continuous glucose monitoring (CGM) market are obtained with maximum precision.
This new 2022 market report provides a holistic analysis of the entire United States continuous glucose monitoring market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States' continuous glucose monitoring market. The report also provides up-to-date historical market size data for the period 2019 - 2021 and an illustrative forecast to 2028 covering key market aspects like market value, volume analysis, and trends for continuous glucose monitoring (CGM) in the United States. A comprehensive comparative analysis has been done on continuous glucose monitoring devices.
This new 2022 market report covers a granular analysis of the present industry situations, and market demands, revealing facts on the market size, CGM volume, revenues for the United States continuous glucose monitoring, and an illustrative forecast for 2028. The report also provides an all-around analysis of the overall number of patients with diabetes and insulin users in the United States. An all-inclusive examination has been done on the pricing, demand, and key development of the continuous glucose monitoring market in the United States. The report also reveals facts, statistics, growth rate, and demand for the continuous glucose monitoring Vs blood glucose meter market in the United States.
Additionally, this up-to-date report describes the latest features of reimbursement patterns and offers a clear view of the regulatory framework of the United States’ continuous glucose monitoring market. Key trends in terms of collaboration and partnership deals are analyzed in detail. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the United States' continuous glucose monitoring market.
The report also analyses detailed profiles of innovative and leading players with information on business overview, product portfolio, and the newest developments. Other emerging players are making innovative technology-based continuous glucose monitoring that is likely to disturb the market share during the forecast period.
The report will serve as a source for a 360-degree analysis, thoroughly integrating different models.
This Newest and Comprehensive the United States Continuous Glucose Monitoring (CGM) Market Research Report 2022 Delivers:
• Comprehensive Research Methodology of the United States Continuous Glucose Monitoring (CGM) Market
• Detailed and Extensive Market Overview with Key Analyst Insights
• Insights about Market Determinants that are Stimulating the United States Continuous Glucose Monitoring (CGM) Market
• To Analyze the Historical Growth in the Market Size of the United States Continuous Glucose Monitoring (CGM) Market from 2018 to 2021
• To Estimate and Forecast the Market Size of the United States Continuous Glucose Monitoring (CGM) from 2022 to 2028 and Growth Rate until 2028
• Detailed Assessment of the United States Continuous Glucose Monitoring (CGM) Users Volume and Forecast to 2028
• Thoroughly Assessment of the United States Continuous Glucose Monitoring (CGM) Vs Blood Glucose Meter (BGM) Market Size and Growth Rate (2019 - 2028)
• Delivers Comprehensive Insights on the Continuous Glucose Monitoring Devices Comparative Analysis
• An Insightful Analysis of the United States Diabetes Population and Forecast to 2028
• Delivers a Complete Overview of the United States Insulin Users and Forecast to 2028
• Delivers Comprehensive Insights into the Regulatory Framework of the United States Continuous Glucose Monitoring (CGM) Market
• Features Reimbursement Patterns of the United States Continuous Glucose Monitoring (CGM) Market
• Delivers an In-Depth Analysis of Evolving Market Trends, Drivers, and Restraints of the United States Continuous Glucose Monitoring (CGM) Market
• Tracks Competitive Developments, Approaches, Recent Industry Developments, Collaboration Deals, and Partnership Deals
• A Comprehensive List of the Leading Companies along with the Analysis of their Current Product Portfolios, Business Overview, and Current Development
The Key Market Players for the United States Continuous Glucose Monitoring (CGM) Market are Listed Below:
• Abbott
• Dexcom, Inc.
• Medtronic, Inc.
• Senseonics Holdings, Inc.
The Report Helps Answer the Following Questions:
• What is the current scenario of the United States’ continuous glucose monitoring?
• What is the total market size and forecast (until 2028) of the United States continuous glucose monitoring?
• How big is the United States continuous glucose monitoring market?
• At what CAGR is the U.S. continuous glucose monitoring market projected to grow in the forecast period (2022-2028)?
• What is the regulatory framework in the United States continuous glucose monitoring market?
• How much do continuous glucose monitors cost?
• What is the reimbursement pattern in the United States Continuous Glucose Monitoring (CGM) market?
• Which companies make continuous glucose monitors?
• What are the key factors driving the United States’ continuous glucose monitoring market?
• What are the key challenges of the United States’ continuous glucose monitoring market?
• What are the major deals and agreements happenings in the United States continuous glucose monitoring market?
• What is the various continuous glucose monitoring available in the United States?
• Who are the topmost market players? What are their happenings, current developments, and scenarios?
• How is the market predicted to develop in the future?
'
1. Executive Summary
2. United States Diabetes Population (2019 – 2028): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes
3. United States Insulin Users and Forecast (2019 – 2027)
4. United States Continuous Glucose Monitoring (CGM) Users Volume Assessment and Market Size 2019 –2028
4.1 Continuous Glucose Monitoring (CGM) Users Volume Assessment
4.2 Continuous Glucose Monitoring (CGM) Market Size and Forecast
5. United States Continuous Glucose Monitoring (CGM) Vs Blood Glucose Meter (BGM) Market Size and Growth Rate (2019 – 2028)
6. United States Continuous Glucose Monitoring Market Growth Drivers and Challenges
6.1 Key Market Growth Drivers
6.2 Key Market Challenges
7. Continuous Glucose Monitoring Devices Comparative Analysis
8. Reimbursement Environment of the United States Continuous Glucose Monitoring Market
9. Regulation Framework of the United States Continuous Glucose Monitoring Market
10. Collaboration Deals in the Continuous Glucose Monitoring Market
11. Partnership Deals in the Continuous Glucose Monitoring Market
12. Key Companies Analysis
12.1 Abbott
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Recent Development
12.2 Dexcom, Inc.
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Recent Development
12.3 Medtronic
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Recent Development
12.4 Senseonics Holdings, Inc.
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Recent Development
List of Tables:
Table 5–1: United States BGM Vs CGM Market Size and Growth Rate
List of Figures:
Figure 2–1: United States Overall Diabetes Population (Thousand), 2019 – 2021
Figure 2–2: United States Overall Diabetes Population Forecast (Thousand), 2022 – 2028
Figure 2–3: United States Type 1 Diabetes Population Forecast (Thousand), 2019 – 2021
Figure 2–4: United States Type 1 Diabetes Population Forecast (Thousand), 2022 – 2028
Figure 2–5: United States Type 2 Diabetes Population (Thousand), 2019 – 2021
Figure 2–6: United States Type 2 Diabetes Population Forecast (Thousand), 2022 – 2028
Figure 2–7: United States Newly Diagnosed Type 1 Diabetes Population (Number), 2019 – 2021
Figure 2–8: United States Newly Diagnosed Type 1 Diabetes Population Forecast (Number), 2022 – 2028
Figure 3–1: United States Insulin Users (Thousand),2019 – 2021
Figure 3–2: United States Insulin Users Forecast (Thousand),2022 – 2028
Figure 4–1: United States Continuous Glucose Monitoring (CGM) Users (Thousand), 2019 – 2021
Figure 4–2: United States Continuous Glucose Monitoring (CGM) Users Forecast (Thousand), 2022 – 2028
Figure 4–3: United States Continuous Glucose Monitoring (CGM) Market (Million US$), 2019 – 2021
Figure 4–4: United States Continuous Glucose Monitoring (CGM) Market (Million US$), 2022 – 2028
Figure 5–1: United States BGM and CGM Growth Rate Line Graph
